Fresenius SE & Co KGaA (FSNUY)
8.78
+0.16
(+1.86%)
USD |
OTCM |
Nov 15, 16:00
Fresenius Market Cap: 19.78B for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 15, 2024 | 19.78B |
| November 14, 2024 | 19.42B |
| November 13, 2024 | 19.59B |
| November 12, 2024 | 19.92B |
| November 11, 2024 | 20.21B |
| November 08, 2024 | 20.59B |
| November 07, 2024 | 20.73B |
| November 06, 2024 | 21.10B |
| November 05, 2024 | 20.93B |
| November 04, 2024 | 20.50B |
| November 01, 2024 | 20.84B |
| October 31, 2024 | 20.66B |
| October 30, 2024 | 20.55B |
| October 29, 2024 | 20.88B |
| October 28, 2024 | 21.11B |
| October 25, 2024 | 20.51B |
| October 24, 2024 | 20.57B |
| October 23, 2024 | 20.23B |
| October 22, 2024 | 20.41B |
| October 21, 2024 | 20.52B |
| October 18, 2024 | 20.46B |
| October 17, 2024 | 20.36B |
| October 16, 2024 | 20.67B |
| October 15, 2024 | 20.69B |
| October 14, 2024 | 20.73B |
| Date | Value |
|---|---|
| October 11, 2024 | 20.68B |
| October 10, 2024 | 20.77B |
| October 09, 2024 | 21.13B |
| October 08, 2024 | 20.97B |
| October 07, 2024 | 20.77B |
| October 04, 2024 | 21.13B |
| October 03, 2024 | 21.16B |
| October 02, 2024 | 21.37B |
| October 01, 2024 | 21.51B |
| September 30, 2024 | 21.58B |
| September 27, 2024 | 21.22B |
| September 26, 2024 | 21.31B |
| September 25, 2024 | 20.91B |
| September 24, 2024 | 21.00B |
| September 23, 2024 | 20.88B |
| September 20, 2024 | 20.98B |
| September 19, 2024 | 21.40B |
| September 18, 2024 | 21.56B |
| September 17, 2024 | 21.58B |
| September 16, 2024 | 21.54B |
| September 13, 2024 | 21.65B |
| September 12, 2024 | 21.13B |
| September 11, 2024 | 21.25B |
| September 10, 2024 | 21.16B |
| September 09, 2024 | 21.05B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.90B
Minimum
Oct 12 2022
31.99B
Maximum
May 24 2021
21.12B
Average
20.49B
Median
Market Cap Benchmarks
| Affimed NV | 54.57M |
| InflaRx NV | 114.82M |
| BioNTech SE | 23.91B |
| Immatics NV | 842.38M |
| CureVac NV | 569.76M |
Market Cap Related Metrics
| PS Ratio | 0.7886 |
| Price to Book Value | 0.9407 |
| Price to Free Cash Flow | 7.933 |
| Price | 8.78 |
| Earnings Yield | -2.03% |
| Operating PE Ratio | 13.08 |
| Normalized PE Ratio | 38.86 |